These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 549000)

  • 21. Effect of renal transplantation on serum oxalate and urinary oxalate excretion.
    Worcester EM; Fellner SK; Nakagawa Y; Coe FL
    Nephron; 1994; 67(4):414-8. PubMed ID: 7969673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
    J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a compensated Jaffe creatinine method on the estimation of glomerular filtration rate.
    Chan MH; Ng KF; Szeto CC; Lit LC; Chow KM; Leung CB; Suen MW; Li PK; Lam CW
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):482-4. PubMed ID: 15588439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function.
    Toffaletti JG; McDonnell EH
    Clin Chim Acta; 2008 Sep; 395(1-2):115-9. PubMed ID: 18573244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of glomerular filtration rate in children.
    Guignard JP; Torrado A; Feldman H; Gautier E
    Helv Paediatr Acta; 1980 Oct; 35(5):437-47. PubMed ID: 7440229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels.
    Tsao CS; Salimi SL
    Int J Vitam Nutr Res; 1984; 54(2-3):245-9. PubMed ID: 6500850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C measurement and its practical use in patients with various renal diseases.
    Tian S; Kusano E; Ohara T; Tabei K; Itoh Y; Kawai T; Asano Y
    Clin Nephrol; 1997 Aug; 48(2):104-8. PubMed ID: 9285147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
    Constable AR; Joekes AM; Kasidas GP; O'Regan P; Rose GA
    Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of serum oxalate using peroxyoxalate chemiluminescence of free oxalic acid.
    Albrecht S; Hornak H; Freidt T; Böhm WD; Weis K; Reinschke A
    J Biolumin Chemilumin; 1993; 8(1):21-4. PubMed ID: 8475780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary oxalate loads and renal oxalate handling.
    Holmes RP; Ambrosius WT; Assimos DG
    J Urol; 2005 Sep; 174(3):943-7; discussion 947. PubMed ID: 16094002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary oxalate and glycolate excretion and plasma oxalate concentration.
    Barratt TM; Kasidas GP; Murdoch I; Rose GA
    Arch Dis Child; 1991 Apr; 66(4):501-3. PubMed ID: 2031609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes.
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    J Urol; 1992 Sep; 148(3 Pt 2):986-9. PubMed ID: 1507356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal elimination kinetics and plasma half-life of oxalate in man.
    Osswald H; Hautmann R
    Urol Int; 1979; 34(6):440-50. PubMed ID: 494445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of plasma oxalate with soluble oxalate oxidase.
    Petrarulo M; Cerelli E; Marangella M; Cosseddu D; Vitale C; Linari F
    Clin Chem; 1994 Nov; 40(11 Pt 1):2030-4. PubMed ID: 7955374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients.
    Wolthers BG; Meijer S; Tepper T; Hayer M; Elzinga H
    Clin Sci (Lond); 1986 Jul; 71(1):41-7. PubMed ID: 3709074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.